Pulse steroids for hard-to-treat rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy clinical trials.
This trial tests whether a high-dose steroid injection can help people with rheumatoid arthritis that hasn't improved with other treatments. If you have RA that's not well controlled, this may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have rheumatoid arthritis that has not responded to other treatments
- You do not have other connective tissue diseases (like lupus or scleroderma)
- You do not have diabetes or thyroid disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of intravenous medicine (called pulse therapy) can help children with arthritis that hasn't improved after other treatments. It aims to bring the disease into remission.
This study tests whether adding roflumilast, a new medication, to your current rheumatoid arthritis treatment can help reduce joint inflammation and improve your symptoms. You would take it alongside methotrexate, a common RA medication you may already be using.
This study tests two ways of slowly lowering your steroid dose (prednisolone) to see which is safer and works better for people with stable rheumatoid arthritis. You may join if you have been on a low, steady dose of steroids and your arthritis is well controlled.
This trial tests whether ultrasound waves applied to the spleen can reduce inflammation in adults with rheumatoid arthritis. It is for people with moderate to severe disease who have not tried many biologic medications.
This study tests whether a very low dose of the steroid prednisolone can safely help people with newly diagnosed rheumatoid arthritis who haven't yet started other treatments. It aims to control symptoms early without the side effects of higher doses.
This trial is for people with rheumatoid arthritis or spondyloarthritis who haven't responded well to standard treatments. It aims to study and improve care for those needing advanced biologic or synthetic therapies.
Hear when a new Active Rheumatoid Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.